Pharmacologic Approaches to the Prevention and Treatment of Bronchopulmonary Dysplasia

Roberts RJ . Drug therapy in infants, pharmacologic principles and clinical experience. Philadelphia: WB Saunders Co, 1984.

Dikshit K , Vyden JK , Forrester JS , . Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 1973;288:1087.

Ikram H , Chan W , Espiner EA , Nicholls MG . Haemodynamic and hormone responses to acute and chronic furosemide therapy in congestive heart failure. Clin Sci 1980;59:443.

Kao LC , Warburton D , Cheng MH , Cedeno C , Platzker ACG , Keens TG . Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: Results of a double-blind crossover sequential trial. Pediatrics 1984;74:37–44.

Najak ZD , Harris EM , Lazzara A , Pruitt AW . Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr 1983;102:758–763.

Kao LC , Warburton D , Sargent CW , Platzker ACG , Keens TG . Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia. J Pediatr 1983;103:624–629.

Patel H , Yeh TF , Jain R , Pildes R. Pulmonary and renal responses to furosemide in infants with stage III-IV bronchopulmonary dysplasia. AJDC 1985;139:917–919.

McCann EM , Lewis K , Deming DD , Donovan J , Brady JP . Controlled trial of furosemide therapy in infants with chronic lung disease. J Pediatr 1985;106:957–962.

Finberg L. Furosemide—uses, abuses, and unsolved puzzles (letter). AJDC 1983;137:1145.

Venkataraman PS , Han BK , Tsang RC , Daugherty CC . Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. AJDC 1983;137:1157–1161.

Rooklin AR , Moomjian AS , Shutack JG , Schwartz JG , Fox WW . Theophylline therapy in bronchopulmonary dysplasia. J Pediatr 1979;95:882–885.

Viscardi RM , Faix RG , Nicks JJ , Grasela TH . Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birthweight infants. J Pediatr 1985;107:469–472.

Howell J , Clozel M , Aranda JV . Adverse effects of caffeine and theophylline in the newborn infant. Sem Perinatol 1981;5:359–369.

Sosulski R , Abbasi S , Fox WW . Therapeutic value of terbutaline in bronchopulmonary dysplasia (abstract). Pediatr Res 1982;16:309A.

Rigaud M , Boschat J , Rocha P , . Comparative haemodynamic effects of dobutamine and isoproterenol in man. Intensive Care Med 1977;3:57.

Rosenblum R , Berkowitz WD , Lawson D. Effect of acute intravenous administration of isoproterenol on cardiorenal hemodynamics in man. Circulation 1968;38:158.

Shettigar UR , Hultgren HN , Specter M , . Primary pulmonary hypertension. Favorable effect of isoproterenol. N Engl J Med 1976;295:1414.

Kao LC , Warburton D , Platzker ACG , Keens TG . Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics 1984;73:509–514.

Morris HG . Mechanisms of glucocorticoid action in pulmonary disease. Chest 1985;88:133S–141S.

Mammel MC , Green TP , Johnson DE , Thompson TR . Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1983;1:1356–1357.

Avery GB , Fletcher AB , Kaplan M , Brudno DS . Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 1985;75:106–111.

Bond WS . Toxic reactions and side effects of glucocorticoids in man. Am J Hosp Pharm 1977;34:479.

deSa DJ . Myocardial changes in immature infants requiring prolonged ventilation. Arch Dis Child 1977;52:138–147.

Milstein JM , Goetzman BW , Bennett SH . Pulmonary vascular response to digoxin. Am J Hosp Pharm 1977;34:479. Pediatr Res 1981;15:468.

Smith TW , Haber E. Digitalis (fourth of four parts). N Engl J Med 1973;289:1125.

Warburton D , Bell EF , Oh W. Pharmacokinetics and echocardiographic effects of digoxin in low birth weight infants with left-to-right shunting due to patent ductus arteriosus. De Pharmacol Ther 1980;1:189.

Friedman WF , George BL . Treatment of congestive heart failure by altering loading conditions of the heart. J Pediatr 1985;106:697–706.

Roberts RJ . Pulmonary oxygen toxicity in the premature and full-term infant its relationship to the development and pathogenesis of RDS and its complications. In: Stern L , ed. Hyaline membrane disease. New York: Grune and Stratton Inc, 1984.

Halliday HL , Dumpit FM , Brady JP . Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics 1980;65:536–540.

Abman SH , Wolfe RR , Accurso FJ , Koops BL , Bowman M , Wiggins JW . Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985;75:80–84.

Drummond WH , Lock JE . Neonatal 'pulmonary vasodilator' drugs. Dev Pharmacol Ther 1984;7:1–20.

Hyman AL , Kadowitz PJ . Vasodilator therapy for pulmonary hypertensive disorders (editorial). Chest 1984;85:145–147.

Borman JB , Merin G , Majblum S , . The beneficial effects of chlorpromazine on pulmonary hemodynamics after cardiopulmonary bypass. Ann Thorac Surg 1971;11:570.

Runkle B , Bancalari E. Acute cardiopulmonary effects of pancuronium bromide in mechanically ventilated newborn infants. J Pediatr 1984;104:614–617.

Nickerson BG . Chronic pulmonary disease following neonatal respiratory failure. Chest 1985;87:528–535.

Roberts RJ . Implications of nutrition in oxygen-related pulmonary disease in the human premature infant. Adv Pharm Ther 1978;8:53–64.

White CW , Repine JE . Pulmonary antioxidant defense mechanisms. Exp Lung Res 1985;8:81–96.

Ehrenkranz RA , Ablow RC , Warshaw JB . Effect of vitamin E on the development of oxygen-induced lung injury in neonates. Ann NY Acad Sci 1982;393:452–458.

Ward JA , Roberts RJ . Vitamin E inhibition of the effects of hyperoxia on the pulmonary surfactant system of the newborn rabbit. Pediatr Res 1984;18:329–334.

Rosenfeld W , Evans H , Concepcion L , Jhaveri R , Schaeffer H , Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984;105:781–785.

Enhorning G , Sherman A , Possmayer F , Dunn M , Chen CP , Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics 1985;76:145–153.

Shapiro DL , Notter RH , Morin FC , . Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 1985;76:593–599.

Kwong MS , Egan EA , Notter RH , Shapiro DL . Double blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985;76:585–592.